Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002–2019)

BACKGROUND: Improvements in glycemic outcomes have stalled since 2010 in several international surveys. We previously reported improvements in glycemic control in 2007-2014 in Hong Kong coinciding with primary care reforms, use of dipeptidyl-peptidase 4 inhibitors (DPP-4is) and metformin. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Aimin, Wu, Hongjiang, Lau, Eric S.H., Zhang, Xinge, Shi, Mai, Fan, Baoqi, Ma, Ronald C.W., Kong, Alice P.S., Luk, Andrea O.Y., Chan, Juliana C.N., Chow, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249907/
https://www.ncbi.nlm.nih.gov/pubmed/35789825
http://dx.doi.org/10.1016/j.lanwpc.2022.100509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249907/
https://www.ncbi.nlm.nih.gov/pubmed/35789825
http://dx.doi.org/10.1016/j.lanwpc.2022.100509

Ejemplares similares